ArticleThe journal of physical chemistry. B2026
Electrostatic Engineering of Phosphoketolase Enhances Activity on Small Nonphosphorylated Sugars and Improves Cell-Free ATP Regeneration from Inexpensive C2-Substrates.
Article in The journal of physical chemistry. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Phosphoketolases can convert nonphosphorylated sugars to the high-energy compound acetyl phosphate and the versatile metabolic precursor acetyl-CoA. However, their application is limited by low catalytic activity toward these substrates. Here, we report the rational engineering of the phosphoketolase from Bifidobacterium adolescentis (Bad.F6Pkt) to enhance its activity and affinity toward glycolaldehyde (GA) and d-erythrulose (ERU) through reorganization of the protein electric field. Guided by predicted induced side-chain pKa shifts, visualization of electrostatic potential difference maps alongside molecular modeling and sequence variation analyses, we identified mutations that could promote in situ ring opening of the predominant cyclic GA dimer. This approach yielded the GA-specific double mutant H142N:E153D, exhibiting a 10-fold improved affinity (KM = 4.4 mM) and slightly enhanced catalytic efficiency compared to the previously reported H142N variant. In addition, the H256Y:H260Y:H548Y variant comprising long-range electrostatic mutations exhibited a 3.8-fold higher catalytic efficiency toward ERU than the wild-type. The engineered enzymes were evaluated in cell-free enzyme cascades for ATP regeneration via acetyl phosphate formation. The H142N variant enabled efficient ATP regeneration from GA and ethylene glycol, whereas H142N:E153D exhibited reduced stability under synthesis conditions. Furthermore, coupling of a d-threose aldolase and isomerase with the PKT triple mutant enabled rapid GA conversion to C4 sugar intermediates, increasing the ATP yield.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.